Lycera lycera.com


Public lists: Pharma Startups (4732)

Lycera is a biopharmaceutical company pioneering approaches to the discovery and development of oral medicines for treating autoimmune diseases. The company is targeting pathways to develop new classes of selective, oral immunomodulators for the treatment of patients with diseases such as rheumatoid arthritis, psoriasis and inflammatory bowel disease. Lycera's goal is to develop drug candidates with efficacy and safety profiles that change the treatment paradigm for patients with autoimmune dise...Show all

Lycera is a biopharmaceutical company pioneering approaches to the discovery and development of oral medicines for treating autoimmune diseases. The company is targeting pathways to develop new classes of selective, oral immunomodulators for the trea...Show all

Company (Alive / Active)

Phone: 734-764-4548

Fax:

2800 Plymouth Road
NCRC, Building 26
Ann Arbor, 48109
Michigan, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Lycera $86.9M Jun 22, 2015
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Lycera Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Competitors

Company Status Description Investors

Echelon Biosciences

Salt Lake City, Utah, United States
Alive / ActiveEchelon Biosciences is a company that received a SBIR Phase I grant for a project entitled: Near Infrared Substrates for Imaging Autotaxin Activity In Vivo. Their project aims to synthesize ATXRed, an in vivo imaging agent that is specifically activated by the enzymatic activity of autotaxin. Autotaxin is an extracellular enzyme that generates the phospholipid growth factor lysophophatidic acid (LPA). LPA is involved in a variety of biological functions, such as angiogenesis, wound healing, brai...Show allLogin to see details

Cellzome

Heidelberg, Germany
AcquiredCellzome is a privately-owned drug discovery company identifying a new generation of kinase- targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by Kinobeads, a technology for the screening and profiling of kinases in relevant cells and tissues.Login to see details
See all 17 competitors